{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:28:05Z","timestamp":1793647685994,"version":"4.5.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.virol.2026.111048","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:31:15Z","timestamp":1786548675000},"page":"111048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Conserved host-exclusive oligonucleotide motifs enriched in pathogenic genes of human oncogenic viruses"],"prefix":"10.1016","volume":"624","author":[{"given":"Alexandros G.","family":"Georgakilas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon N.","family":"Vasilopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Z\u00fclal","family":"Bigi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-6359","authenticated-orcid":false,"given":"Ioly","family":"Kotta-Loizou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Pavlopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.111048_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001022","article-title":"Nullomers: really a matter of natural selection?","volume":"2","author":"Acquisti","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.111048_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.37349\/etat.2024.00209","article-title":"The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates","volume":"5","author":"Agustiningsih","year":"2024","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.virol.2026.111048_bib3","article-title":"Nullomer peptide increases immune cell infiltration and reduces tumor metabolism in triple negative breast cancer mouse model","author":"Ali","year":"2023","journal-title":"Res. square"},{"key":"10.1016\/j.virol.2026.111048_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.peptides.2012.09.015","article-title":"Nullomer derived anticancer peptides (NulloPs): differential lethal effects on normal and cancer cells in vitro","volume":"38","author":"Alileche","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.virol.2026.111048_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12885-017-3514-z","article-title":"The effect of Nullomer-derived peptides 9R, 9S1R and 124R on the NCI-60 panel and normal cell lines","volume":"17","author":"Alileche","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.virol.2026.111048_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13010087","article-title":"HTLV-1 tax Tug-of-War: cellular senescence and death or cellular transformation","volume":"13","author":"Bellon","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2026.111048_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2016.09.008","article-title":"The kaposi's-sarcoma-associated herpesvirus orf35 gene product is required for efficient lytic virus reactivation","volume":"499","author":"Bergson","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.111048_bib8","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001955","article-title":"ICTV virus taxonomy profile: filoviridae 2024","volume":"105","author":"Biedenkopf","year":"2024","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/v17050659","article-title":"Novel minimal absent words detected in influenza A virus","volume":"17","author":"Bigis","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111048_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1101\/gr.1865504","article-title":"GeneWise and genomewise","volume":"14","author":"Birney","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.virol.2026.111048_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013092","article-title":"Epstein-barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism","volume":"21","author":"Burton","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.111048_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1059133","article-title":"EBV-Associated diseases: current therapeutics and emerging technologies","volume":"13","author":"Chakravorty","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111048_bib13","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001712","article-title":"ICTV virus taxonomy profile: retroviridae 2021","volume":"102","author":"Coffin","year":"2021","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib14","first-page":"796","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019, the lancet","volume":"7","author":"Collaborators","year":"2022","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2026.111048_bib15","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1074\/jbc.M209840200","article-title":"Epstein-barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase\/Akt pathway to promote cell survival and induce actin filament remodeling","volume":"278","author":"Dawson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2026.111048_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","article-title":"WHO 2024 hepatitis B guidelines: an opportunity to transform care","volume":"9","author":"Easterbrook","year":"2024","journal-title":"Lancet. Gastroenterol. & Hepatol."},{"key":"10.1016\/j.virol.2026.111048_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4254\/wjh.v7.i6.831","article-title":"Hepatitis C virus genetic variability and evolution","volume":"7","author":"Echeverria","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.virol.2026.111048_bib18","article-title":"Beyond immortality: Epstein-Barr virus and the intricate dance of programmed cell death in cancer development","volume":"43","author":"Esmaeili","year":"2025","journal-title":"Cancer Treatm. Res. Commun."},{"key":"10.1016\/j.virol.2026.111048_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: epidemiology, causes, trends and predictions","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virol.2026.111048_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41568-022-00490-1","article-title":"Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies","volume":"22","author":"Gao","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.virol.2026.111048_bib21","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001673","article-title":"ICTV virus taxonomy profile: herpesviridae 2021","volume":"102","author":"Gatherer","year":"2021","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib22","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1182\/bloodadvances.2020001675","article-title":"Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery","volume":"4","author":"Gazon","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.virol.2026.111048_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.45","article-title":"Highly heterogeneous mutation rates in the hepatitis C virus genome","volume":"1","author":"Geller","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virol.2026.111048_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13059-021-02459-z","article-title":"Absent from DNA and protein: genomic characterization of nullomers and nullpeptides across functional categories and evolution","volume":"22","author":"Georgakopoulos-Soares","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.virol.2026.111048_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1097-2765(04)00091-7","article-title":"Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover","volume":"13","author":"Glaunsinger","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.virol.2026.111048_bib26","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1097\/QAD.0000000000004194","article-title":"Kaposi sarcoma: today, yesterday, and tomorrow","volume":"39","author":"Goedert","year":"2025","journal-title":"Aids"},{"key":"10.1016\/j.virol.2026.111048_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02169-20","article-title":"Kaposi's sarcoma-associated herpesvirus processivity factor, ORF59, binds to canonical and linker histones, and its carboxy terminus is dispensable for viral DNA synthesis","volume":"95","author":"Gutierrez","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib28","series-title":"Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing","first-page":"355","article-title":"Absent sequences: nullomers and primes","author":"Hampikian","year":"2007"},{"key":"10.1016\/j.virol.2026.111048_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41590-020-00817-w","article-title":"Memory-like HCV-specific CD8(+) T cells retain a molecular scar after cure of chronic HCV infection","volume":"22","author":"Hensel","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2026.111048_bib30","doi-asserted-by":"crossref","first-page":"10989","DOI":"10.1073\/pnas.1832776100","article-title":"The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold","volume":"100","author":"Humme","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.virol.2026.111048_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13027-019-0246-5","article-title":"CRISPR\/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth","volume":"14","author":"Huo","year":"2019","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.virol.2026.111048_bib32","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.virol.2026.111048_bib33","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1128\/JVI.06900-11","article-title":"Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion","volume":"86","author":"Kannian","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib34","first-page":"14","article-title":"Molecular mechanisms of Kaposi Sarcoma development","author":"Karabajakian","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.virol.2026.111048_bib35","first-page":"35","article-title":"EBNA2 and its coactivator EBNA-LP","volume":"391","author":"Kempkes","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2026.111048_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1440-1746.2010.06546.x","article-title":"Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma","volume":"26","author":"Kew","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2026.111048_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.semcancer.2021.05.031","article-title":"Insights into the role of complement regulatory proteins in HPV mediated cervical carcinogenesis","volume":"86","author":"Khan","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.virol.2026.111048_bib38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s12276-024-01207-0","article-title":"Viral remodeling of the 4D nucleome","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.virol.2026.111048_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0168-8278(01)00171-4","article-title":"In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease","volume":"35","author":"Kitada","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2026.111048_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41467-022-34828-y","article-title":"Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal species","volume":"14","author":"Klughammer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111048_bib41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.chom.2022.06.008","article-title":"The logic of virus evolution","volume":"30","author":"Koonin","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2026.111048_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/v10020082","article-title":"DNA tumor virus regulation of host DNA methylation and its implications for immune evasion and oncogenesis","volume":"10","author":"Kuss-Duerkop","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111048_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11091039","article-title":"Determinants of virus variation, evolution, and host adaptation","volume":"11","author":"LaTourrette","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2026.111048_bib44","series-title":"Transcriptional Regulation of Gene Modules in Epstein-Barr Virus, Transcription","first-page":"1","author":"Lieberman","year":"2025"},{"key":"10.1016\/j.virol.2026.111048_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1099\/jgv.0.001415","article-title":"ICTV virus taxonomy profile: hepadnaviridae","volume":"101","author":"Magnius","year":"2020","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib46","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1038\/s41467-024-53658-8","article-title":"Molecular mimicry as a mechanism of viral immune evasion and autoimmunity","volume":"15","author":"Maguire","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111048_bib47","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood-2005-11-4404","article-title":"Kaposi sarcoma herpesvirus K5 removes CD31\/PECAM from endothelial cells","volume":"108","author":"Mansouri","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.virol.2026.111048_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","article-title":"Human papillomaviruses: diversity, infection and host interactions","volume":"20","author":"McBride","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2026.111048_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2516.2011.02575.x","article-title":"HCV-related liver cancer in people with haemophilia","volume":"18","author":"Meijer","year":"2012","journal-title":"Haemophilia : Off. J. World Feder. Hemophil."},{"key":"10.1016\/j.virol.2026.111048_bib50","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.csbj.2024.05.025","article-title":"A survey of k-mer methods and applications in bioinformatics","volume":"23","author":"Moeckel","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.virol.2026.111048_bib51","first-page":"9","article-title":"Mechanisms of oncogenesis by HTLV-1 tax","author":"Mohanty","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2026.111048_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41417-024-00741-3","article-title":"Utilizing nullomers in cell-free RNA for early cancer detection","volume":"31","author":"Montgomery","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.virol.2026.111048_bib53","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1128\/JVI.75.6.2866-2878.2001","article-title":"Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus","volume":"75","author":"Nealon","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib54","article-title":"Kaposi's sarcoma-associated herpesvirus ORF6 gene is essential in viral lytic replication","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.111048_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2105-10-137","article-title":"On finding minimal absent words","volume":"10","author":"Pinho","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.virol.2026.111048_bib56","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.virol.2026.111048_bib57","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1093\/bioinformatics\/btaa686","article-title":"Persistent minimal sequences of SARS-CoV-2","volume":"36","author":"Pratas","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2026.111048_bib58","article-title":"The intersection of virus infection and liver disease: a comprehensive review of pathogenesis, diagnosis, and treatment","volume":"16","author":"Ren","year":"2024","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.virol.2026.111048_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/v14050986","article-title":"Hepatitis B virus-associated hepatocellular carcinoma","volume":"14","author":"Rizzo","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111048_bib60","first-page":"1","article-title":"An Introduction to Virus Infections and Human Cancer, Recent results in cancer research. Fortschritte der Krebsforschung","volume":"217","author":"Schiller","year":"2021","journal-title":"Progres dans les recherches sur le cancer"},{"key":"10.1016\/j.virol.2026.111048_bib61","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/bioinformatics\/btv189","article-title":"Three minimal sequences found in Ebola virus genomes and absent from human DNA","volume":"31","author":"Silva","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2026.111048_bib62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41579-018-0120-2","article-title":"Prisoners of war - host adaptation and its constraints on virus evolution","volume":"17","author":"Simmonds","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2026.111048_bib63","article-title":"Epigenetic and epitranscriptomic regulation during oncogenic gamma-herpesvirus infection","volume":"15","author":"Singh","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.111048_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9061179","article-title":"Viral manipulation of the host epigenome as a driver of virus-induced oncogenesis","volume":"9","author":"Soliman","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.virol.2026.111048_bib65","first-page":"973","article-title":"Activation of DNA methyltransferase 3a by Epstein-Barr nuclear antigen 1 in gastric carcinoma","volume":"54","author":"Song","year":"2022","journal-title":"Dig. Liver Dis., Off. J. Italian Soc. Gastroenterol. Italian Assoc. Study Liver"},{"key":"10.1016\/j.virol.2026.111048_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/v17010110","article-title":"Targeting EBV episome for anti-cancer therapy: emerging strategies and challenges","volume":"17","author":"Sugiokto","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111048_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/biology14070797","article-title":"The impact of oncogenic viruses on cancer development: a narrative review","volume":"14","author":"Torres","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.virol.2026.111048_bib68","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-14-0572","article-title":"Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research","volume":"20","author":"Tsukasaki","year":"2014","journal-title":"Clin. Cancer Res. : Off. J. Amer. Assoc. Cancer Res."},{"key":"10.1016\/j.virol.2026.111048_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/v9040075","article-title":"HBV DNA integration: molecular mechanisms and clinical implications","volume":"9","author":"Tu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111048_bib70","article-title":"The DNase activity of Kaposi's sarcoma-associated Herpesvirus SOX protein serves an important role in viral genome processing during lytic replication","volume":"93","author":"Uppal","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164540","article-title":"Nullomers and high order nullomers in genomic sequences","volume":"11","author":"Vergni","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.111048_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1322892","article-title":"Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.111048_bib72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virol.2009.11.031","article-title":"Transcriptional regulation of the ORF61 and ORF60 genes of Kaposi's sarcoma-associated herpesvirus","volume":"397","author":"Wang","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.111048_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01000-24","article-title":"Conserved cysteine residues in Kaposi's sarcoma herpesvirus ORF34 are necessary for viral production and viral pre-initiation complex formation","volume":"98","author":"Watanabe","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111048_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virusres.2016.11.023","article-title":"Evasion of host immune defenses by human papillomavirus","volume":"231","author":"Westrich","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2026.111048_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040109","article-title":"EBNA1: oncogenic activity, immune evasion and biochemical functions provide targets for novel therapeutic strategies against Epstein-Barr Virus- associated cancers","volume":"10","author":"Wilson","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.virol.2026.111048_bib77","first-page":"32","article-title":"HPV and cervical cancer-biology, prevention, and treatment updates","author":"Wloszek","year":"2025","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.virol.2026.111048_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of epstein-barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.virol.2026.111048_bib79","series-title":"Hepatitis B","year":"2025"},{"key":"10.1016\/j.virol.2026.111048_bib80","series-title":"Hepatitis C","year":"2025"},{"key":"10.1016\/j.virol.2026.111048_bib81","doi-asserted-by":"crossref","first-page":"16261","DOI":"10.1074\/jbc.RA118.005531","article-title":"Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerization","volume":"293","author":"Wu","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2026.111048_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","article-title":"Viral oncogenesis in cancer: from mechanisms to therapeutics","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virol.2026.111048_bib83","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1182\/blood-2003-05-1490","article-title":"HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro","volume":"102","author":"Ye","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.virol.2026.111048_bib84","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.virol.2026.111048_bib85","article-title":"HPV16 and HPV18 genome structure, expression, and post-transcriptional regulation","volume":"23","author":"Yu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.111048_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00027-20","article-title":"Beyond cytomegalovirus and epstein-barr virus: a review of viruses composing the blood virome of solid organ transplant and hematopoietic stem cell transplant recipients","volume":"33","author":"Zanella","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2026.111048_bib87","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","article-title":"The landscape of viral associations in human cancers","volume":"52","author":"Zapatka","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virol.2026.111048_bib88","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/aps.2017.17","article-title":"Human T-cell lymphotropic virus type 1 and its oncogenesis","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.virol.2026.111048_bib89","article-title":"Epstein-barr viruses: their immune evasion strategies and implications for autoimmune diseases","volume":"25","author":"Zhao","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.111048_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28424","article-title":"HTLV-1 persistent infection and ATLL oncogenesis","volume":"95","author":"Zuo","year":"2023","journal-title":"J. Med. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226002631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226002631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:52:44Z","timestamp":1793645564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226002631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":90,"alternative-id":["S0042682226002631"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.111048","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conserved host-exclusive oligonucleotide motifs enriched in pathogenic genes of human oncogenic viruses","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.111048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111048"}}